BDSX
Biodesix, Inc.NASDAQHealthcare$15.36+1.92%ClosedMarket Cap: $116.0M
As of 2026-04-07
Analyst Consensus
Consensus
Buy
Target (Consensus)
$8.67
Target (Median)
$3.00
Target Range
$3.00 - $20.00
Upside from current price: -43.6%
Rating Distribution
0 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-02-27 | William Blair | upgrade | Outperform | Market Perform |
| 2026-02-17 | Canaccord Genuity | maintain | Buy | Buy |
| 2025-09-19 | Canaccord Genuity | maintain | Buy | Buy |
| 2025-05-21 | Scotiabank | maintain | Sector Outperform | Sector Outperform |
| 2025-05-14 | Canaccord Genuity | maintain | Buy | Buy |
| 2025-05-14 | William Blair | downgrade | Market Perform | Outperform |
| 2025-05-14 | Lake Street | maintain | Buy | Buy |
| 2025-05-14 | Craig-Hallum | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.95 | $129.4M | 3 |
| Sun Dec 31 | $-1.33 | $152.1M | 2 |
| Mon Dec 31 | $-0.68 | $171.5M | 1 |
| Tue Dec 31 | $-0.24 | $193.6M | 1 |